avrg: GSE58827: Dynamics of the Mouse Liver
Gene Symbol | Gene ID | Gene Info |
---|---|---|
Erg
|
ENSMUSG00000040732.12 | ETS transcription factor |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
Erg | mm10_v2_chr16_-_95459245_95459384 | 0.84 | 9.5e-11 | Click! |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
24.3 | 72.9 | GO:0002148 | hypochlorous acid metabolic process(GO:0002148) hypochlorous acid biosynthetic process(GO:0002149) |
6.8 | 20.5 | GO:0070488 | neutrophil aggregation(GO:0070488) |
3.8 | 11.4 | GO:0002865 | regulation of type IV hypersensitivity(GO:0001807) negative regulation of acute inflammatory response to antigenic stimulus(GO:0002865) negative regulation of hypersensitivity(GO:0002884) |
3.6 | 10.7 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
2.7 | 8.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
2.7 | 13.3 | GO:0051140 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
2.6 | 10.4 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) meiotic metaphase plate congression(GO:0051311) |
2.6 | 7.8 | GO:2000451 | immune complex clearance(GO:0002434) immune complex clearance by monocytes and macrophages(GO:0002436) astrocyte chemotaxis(GO:0035700) regulation of immune complex clearance by monocytes and macrophages(GO:0090264) positive regulation of immune complex clearance by monocytes and macrophages(GO:0090265) negative regulation of eosinophil activation(GO:1902567) positive regulation of CD8-positive, alpha-beta T cell extravasation(GO:2000451) regulation of astrocyte chemotaxis(GO:2000458) |
2.6 | 2.6 | GO:0032752 | positive regulation of interleukin-3 production(GO:0032752) interleukin-3 biosynthetic process(GO:0042223) regulation of interleukin-3 biosynthetic process(GO:0045399) positive regulation of interleukin-3 biosynthetic process(GO:0045401) positive regulation of granulocyte macrophage colony-stimulating factor biosynthetic process(GO:0045425) |
2.4 | 14.2 | GO:0002528 | regulation of vascular permeability involved in acute inflammatory response(GO:0002528) |
2.2 | 8.6 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.1 | 14.6 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) |
2.0 | 8.1 | GO:0035744 | T-helper 1 cell cytokine production(GO:0035744) |
2.0 | 3.9 | GO:0071608 | macrophage inflammatory protein-1 alpha production(GO:0071608) |
1.8 | 7.2 | GO:0038094 | Fc-gamma receptor signaling pathway(GO:0038094) |
1.7 | 11.8 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
1.7 | 13.3 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
1.6 | 4.7 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
1.4 | 5.7 | GO:0033370 | protein localization to secretory granule(GO:0033366) protein localization to mast cell secretory granule(GO:0033367) protease localization to mast cell secretory granule(GO:0033368) maintenance of protein location in mast cell secretory granule(GO:0033370) T cell secretory granule organization(GO:0033371) maintenance of protease location in mast cell secretory granule(GO:0033373) protein localization to T cell secretory granule(GO:0033374) protease localization to T cell secretory granule(GO:0033375) maintenance of protein location in T cell secretory granule(GO:0033377) maintenance of protease location in T cell secretory granule(GO:0033379) granzyme B localization to T cell secretory granule(GO:0033380) maintenance of granzyme B location in T cell secretory granule(GO:0033382) |
1.4 | 5.6 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
1.3 | 7.9 | GO:0006868 | glutamine transport(GO:0006868) |
1.3 | 8.9 | GO:0002322 | B cell proliferation involved in immune response(GO:0002322) |
1.2 | 3.7 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
1.2 | 7.3 | GO:1903336 | endosome localization(GO:0032439) negative regulation of vacuolar transport(GO:1903336) |
1.2 | 3.6 | GO:0051659 | positive regulation of endoplasmic reticulum calcium ion concentration(GO:0032470) maintenance of mitochondrion location(GO:0051659) relaxation of skeletal muscle(GO:0090076) |
1.2 | 14.1 | GO:0070474 | positive regulation of uterine smooth muscle contraction(GO:0070474) |
1.2 | 5.8 | GO:0034436 | glycoprotein transport(GO:0034436) |
1.1 | 11.4 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.1 | 4.6 | GO:0086053 | AV node cell to bundle of His cell communication by electrical coupling(GO:0086053) |
1.1 | 4.5 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
1.1 | 15.9 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
1.0 | 10.3 | GO:1902563 | regulation of neutrophil degranulation(GO:0043313) regulation of neutrophil activation(GO:1902563) |
1.0 | 6.1 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
1.0 | 5.0 | GO:0022007 | neural plate elongation(GO:0014022) convergent extension involved in neural plate elongation(GO:0022007) |
0.9 | 21.7 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
0.9 | 13.6 | GO:0097067 | cellular response to thyroid hormone stimulus(GO:0097067) |
0.9 | 4.4 | GO:1903527 | positive regulation of membrane tubulation(GO:1903527) |
0.9 | 11.4 | GO:0072378 | blood coagulation, fibrin clot formation(GO:0072378) |
0.8 | 3.4 | GO:0010286 | heat acclimation(GO:0010286) |
0.8 | 11.0 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.8 | 6.5 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
0.8 | 4.9 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.8 | 4.0 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
0.8 | 3.2 | GO:0002370 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
0.8 | 4.0 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.8 | 12.7 | GO:0006968 | cellular defense response(GO:0006968) |
0.8 | 6.9 | GO:0038203 | TORC2 signaling(GO:0038203) |
0.8 | 5.3 | GO:2000002 | negative regulation of DNA damage checkpoint(GO:2000002) |
0.8 | 2.3 | GO:1901355 | response to rapamycin(GO:1901355) |
0.7 | 6.0 | GO:1901164 | negative regulation of trophoblast cell migration(GO:1901164) |
0.7 | 2.1 | GO:1904976 | response to bleomycin(GO:1904975) cellular response to bleomycin(GO:1904976) |
0.7 | 5.0 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.7 | 5.6 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.7 | 4.8 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.7 | 3.4 | GO:0038032 | termination of G-protein coupled receptor signaling pathway(GO:0038032) |
0.7 | 2.0 | GO:0032685 | negative regulation of granulocyte macrophage colony-stimulating factor production(GO:0032685) negative regulation of interleukin-18 production(GO:0032701) |
0.7 | 2.7 | GO:0002283 | neutrophil activation involved in immune response(GO:0002283) |
0.6 | 1.9 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.6 | 5.1 | GO:0015919 | peroxisomal membrane transport(GO:0015919) protein import into peroxisome membrane(GO:0045046) |
0.6 | 3.1 | GO:0021993 | initiation of neural tube closure(GO:0021993) |
0.6 | 1.8 | GO:2000349 | negative regulation of CD40 signaling pathway(GO:2000349) |
0.6 | 3.6 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
0.6 | 2.3 | GO:0032053 | ciliary basal body organization(GO:0032053) |
0.6 | 8.1 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
0.6 | 5.7 | GO:0019336 | phenol-containing compound catabolic process(GO:0019336) |
0.6 | 3.4 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.5 | 1.6 | GO:2000043 | endodermal cell fate determination(GO:0007493) stem cell fate specification(GO:0048866) regulation of cardiac cell fate specification(GO:2000043) |
0.5 | 3.8 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
0.5 | 1.1 | GO:0051892 | negative regulation of cardioblast differentiation(GO:0051892) |
0.5 | 6.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.5 | 1.6 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.5 | 2.6 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
0.5 | 1.0 | GO:0060137 | maternal process involved in parturition(GO:0060137) |
0.5 | 4.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.5 | 2.0 | GO:0031296 | B cell costimulation(GO:0031296) |
0.5 | 1.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) embryonic hindgut morphogenesis(GO:0048619) |
0.5 | 2.9 | GO:0050917 | sensory perception of sweet taste(GO:0050916) sensory perception of umami taste(GO:0050917) |
0.5 | 1.9 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.5 | 1.4 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.5 | 2.4 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.5 | 3.8 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
0.5 | 5.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.5 | 1.8 | GO:1902340 | telomeric heterochromatin assembly(GO:0031509) negative regulation of chromosome condensation(GO:1902340) |
0.5 | 1.8 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.4 | 3.6 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.4 | 1.8 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
0.4 | 1.3 | GO:1904959 | regulation of electron carrier activity(GO:1904732) regulation of cytochrome-c oxidase activity(GO:1904959) |
0.4 | 3.5 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.4 | 6.1 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.4 | 4.8 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.4 | 3.7 | GO:0048251 | elastic fiber assembly(GO:0048251) cellular response to UV-B(GO:0071493) |
0.4 | 2.5 | GO:0006543 | glutamine catabolic process(GO:0006543) |
0.4 | 1.6 | GO:1904425 | negative regulation of GTP binding(GO:1904425) |
0.4 | 1.2 | GO:0072276 | metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
0.4 | 7.5 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.4 | 1.5 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.4 | 1.5 | GO:0032847 | regulation of nitrogen utilization(GO:0006808) nitrogen utilization(GO:0019740) regulation of cellular pH reduction(GO:0032847) |
0.4 | 1.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.4 | 1.1 | GO:0006742 | NADP catabolic process(GO:0006742) |
0.4 | 6.5 | GO:0042730 | fibrinolysis(GO:0042730) |
0.3 | 1.0 | GO:0070543 | response to linoleic acid(GO:0070543) |
0.3 | 1.7 | GO:0090273 | regulation of somatostatin secretion(GO:0090273) |
0.3 | 1.0 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 1.0 | GO:0099548 | trans-synaptic signaling by nitric oxide(GO:0099548) |
0.3 | 4.7 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.3 | 1.3 | GO:0032960 | positive regulation of norepinephrine secretion(GO:0010701) regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.3 | 1.0 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.3 | 8.9 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.3 | 1.9 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.3 | 2.2 | GO:0030263 | apoptotic chromosome condensation(GO:0030263) |
0.3 | 5.3 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.9 | GO:0002304 | gamma-delta intraepithelial T cell differentiation(GO:0002304) CD8-positive, gamma-delta intraepithelial T cell differentiation(GO:0002305) |
0.3 | 0.9 | GO:2000435 | regulation of protein neddylation(GO:2000434) negative regulation of protein neddylation(GO:2000435) |
0.3 | 3.0 | GO:0051256 | mitotic spindle midzone assembly(GO:0051256) |
0.3 | 10.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.3 | 1.5 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.3 | 0.6 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.3 | 1.2 | GO:1901228 | positive regulation of transcription from RNA polymerase II promoter involved in heart development(GO:1901228) |
0.3 | 2.3 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.3 | 3.0 | GO:0071280 | cellular response to copper ion(GO:0071280) |
0.3 | 0.8 | GO:0001928 | regulation of exocyst assembly(GO:0001928) |
0.3 | 2.9 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.3 | 5.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 5.0 | GO:0007190 | activation of adenylate cyclase activity(GO:0007190) |
0.3 | 11.0 | GO:0048821 | erythrocyte development(GO:0048821) |
0.3 | 5.4 | GO:0002467 | germinal center formation(GO:0002467) |
0.3 | 1.0 | GO:0010726 | positive regulation of hydrogen peroxide metabolic process(GO:0010726) |
0.3 | 1.5 | GO:1903690 | negative regulation of wound healing, spreading of epidermal cells(GO:1903690) |
0.2 | 5.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.7 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.2 | 0.7 | GO:0001788 | antibody-dependent cellular cytotoxicity(GO:0001788) type III hypersensitivity(GO:0001802) regulation of type III hypersensitivity(GO:0001803) positive regulation of type III hypersensitivity(GO:0001805) |
0.2 | 7.8 | GO:0019731 | antibacterial humoral response(GO:0019731) |
0.2 | 1.4 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.2 | 10.6 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.2 | 1.8 | GO:1901844 | regulation of cell communication by electrical coupling involved in cardiac conduction(GO:1901844) |
0.2 | 5.6 | GO:0043486 | histone exchange(GO:0043486) |
0.2 | 5.7 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.2 | 1.8 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 6.4 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
0.2 | 4.1 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.2 | 5.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
0.2 | 0.8 | GO:0070213 | protein auto-ADP-ribosylation(GO:0070213) |
0.2 | 2.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.2 | 0.4 | GO:1990859 | cellular response to endothelin(GO:1990859) |
0.2 | 2.2 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.2 | 2.9 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
0.2 | 19.4 | GO:0030168 | platelet activation(GO:0030168) |
0.2 | 3.6 | GO:0043374 | CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
0.2 | 3.2 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
0.2 | 2.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 2.9 | GO:0015809 | arginine transport(GO:0015809) |
0.2 | 0.7 | GO:0098884 | postsynaptic neurotransmitter receptor internalization(GO:0098884) |
0.2 | 2.0 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
0.2 | 13.4 | GO:0007596 | blood coagulation(GO:0007596) |
0.2 | 4.6 | GO:0051482 | positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway(GO:0051482) |
0.2 | 1.3 | GO:1903003 | positive regulation of protein deubiquitination(GO:1903003) |
0.2 | 5.3 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.2 | 2.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.2 | 0.6 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
0.2 | 0.5 | GO:0071639 | positive regulation of monocyte chemotactic protein-1 production(GO:0071639) |
0.2 | 1.8 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.2 | 1.8 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 2.0 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 1.5 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) |
0.1 | 1.3 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.1 | 2.6 | GO:0001911 | negative regulation of leukocyte mediated cytotoxicity(GO:0001911) |
0.1 | 4.7 | GO:0015804 | neutral amino acid transport(GO:0015804) |
0.1 | 3.8 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.1 | 0.5 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
0.1 | 2.8 | GO:0000028 | ribosomal small subunit assembly(GO:0000028) |
0.1 | 1.0 | GO:0032625 | interleukin-21 production(GO:0032625) interleukin-21 secretion(GO:0072619) |
0.1 | 1.2 | GO:0045759 | negative regulation of action potential(GO:0045759) |
0.1 | 7.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.1 | 7.9 | GO:0042100 | B cell proliferation(GO:0042100) |
0.1 | 0.5 | GO:0040010 | positive regulation of growth rate(GO:0040010) |
0.1 | 1.3 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.1 | 1.3 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.1 | 1.3 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.1 | 0.3 | GO:0002946 | tRNA C5-cytosine methylation(GO:0002946) |
0.1 | 2.4 | GO:0033235 | positive regulation of protein sumoylation(GO:0033235) |
0.1 | 1.8 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
0.1 | 0.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 3.9 | GO:0042982 | amyloid precursor protein metabolic process(GO:0042982) |
0.1 | 0.6 | GO:0090383 | phagosome acidification(GO:0090383) |
0.1 | 1.9 | GO:0007095 | mitotic G2 DNA damage checkpoint(GO:0007095) |
0.1 | 4.3 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.1 | 0.5 | GO:1901552 | positive regulation of endothelial cell development(GO:1901552) positive regulation of establishment of endothelial barrier(GO:1903142) |
0.1 | 7.5 | GO:0016525 | negative regulation of angiogenesis(GO:0016525) |
0.1 | 0.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
0.1 | 1.1 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.1 | 1.3 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 2.2 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 1.6 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 2.9 | GO:0006379 | mRNA cleavage(GO:0006379) |
0.1 | 1.1 | GO:0021694 | cerebellar Purkinje cell layer formation(GO:0021694) |
0.1 | 0.7 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.1 | 0.2 | GO:0003430 | growth plate cartilage chondrocyte growth(GO:0003430) |
0.1 | 0.8 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) |
0.1 | 0.9 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 1.2 | GO:0010824 | regulation of centrosome duplication(GO:0010824) |
0.1 | 0.5 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
0.1 | 0.7 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.1 | 0.4 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.1 | 2.9 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
0.1 | 2.0 | GO:0007099 | centriole replication(GO:0007099) |
0.1 | 2.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
0.1 | 0.7 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.1 | 3.2 | GO:2000649 | regulation of sodium ion transmembrane transporter activity(GO:2000649) |
0.1 | 0.3 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.1 | 0.2 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 2.5 | GO:0051567 | histone H3-K9 methylation(GO:0051567) |
0.1 | 0.4 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.0 | 1.4 | GO:0045761 | regulation of adenylate cyclase activity(GO:0045761) |
0.0 | 1.6 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.0 | 0.1 | GO:0071544 | diphosphoinositol polyphosphate catabolic process(GO:0071544) |
0.0 | 2.1 | GO:0007091 | metaphase/anaphase transition of mitotic cell cycle(GO:0007091) |
0.0 | 1.5 | GO:0033119 | negative regulation of RNA splicing(GO:0033119) |
0.0 | 1.0 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.0 | 0.7 | GO:0008210 | estrogen metabolic process(GO:0008210) |
0.0 | 0.4 | GO:0000479 | endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000479) |
0.0 | 2.4 | GO:0036465 | synaptic vesicle recycling(GO:0036465) |
0.0 | 0.2 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.0 | 0.2 | GO:0000492 | box C/D snoRNP assembly(GO:0000492) |
0.0 | 2.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
0.0 | 0.1 | GO:0048149 | behavioral response to ethanol(GO:0048149) |
0.0 | 2.1 | GO:0042113 | B cell activation(GO:0042113) |
0.0 | 1.3 | GO:0042632 | cholesterol homeostasis(GO:0042632) sterol homeostasis(GO:0055092) |
0.0 | 1.9 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.0 | 1.0 | GO:0002181 | cytoplasmic translation(GO:0002181) |
0.0 | 0.1 | GO:0099590 | neurotransmitter receptor internalization(GO:0099590) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 1.1 | GO:0006367 | transcription initiation from RNA polymerase II promoter(GO:0006367) |
0.0 | 0.2 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.7 | GO:0034605 | cellular response to heat(GO:0034605) |
0.0 | 0.8 | GO:0071277 | cellular response to calcium ion(GO:0071277) |
0.0 | 0.7 | GO:0006360 | transcription from RNA polymerase I promoter(GO:0006360) |
0.0 | 1.1 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 2.8 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 1.1 | GO:0031497 | chromatin assembly(GO:0031497) |
0.0 | 1.3 | GO:0008203 | cholesterol metabolic process(GO:0008203) |
0.0 | 0.8 | GO:0031338 | regulation of vesicle fusion(GO:0031338) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.3 | 69.0 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
2.9 | 11.8 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
1.9 | 5.6 | GO:0005607 | laminin-2 complex(GO:0005607) |
1.5 | 7.5 | GO:0031680 | G-protein beta/gamma-subunit complex(GO:0031680) |
1.3 | 4.0 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) inhibin A complex(GO:0043512) |
1.3 | 4.0 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
1.1 | 7.7 | GO:0019815 | B cell receptor complex(GO:0019815) |
1.0 | 3.8 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
1.0 | 11.4 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
0.9 | 7.6 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.9 | 4.7 | GO:0042583 | chromaffin granule(GO:0042583) |
0.9 | 3.7 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 10.4 | GO:0072687 | meiotic spindle(GO:0072687) |
0.8 | 10.7 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.8 | 3.2 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.7 | 13.3 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.7 | 2.2 | GO:0030905 | retromer, tubulation complex(GO:0030905) |
0.7 | 2.9 | GO:0008623 | CHRAC(GO:0008623) |
0.7 | 0.7 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.7 | 2.1 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.6 | 3.8 | GO:0097443 | sorting endosome(GO:0097443) |
0.6 | 3.8 | GO:0031673 | H zone(GO:0031673) |
0.6 | 7.3 | GO:0005687 | U4 snRNP(GO:0005687) |
0.6 | 14.3 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 5.7 | GO:0042629 | mast cell granule(GO:0042629) |
0.5 | 3.5 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
0.5 | 11.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.5 | 1.5 | GO:0005940 | septin ring(GO:0005940) |
0.4 | 6.9 | GO:0031932 | TORC2 complex(GO:0031932) |
0.4 | 2.1 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.4 | 3.8 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.4 | 2.0 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 1.5 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
0.4 | 3.6 | GO:0001739 | sex chromatin(GO:0001739) |
0.4 | 1.4 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 21.6 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
0.3 | 2.7 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 14.7 | GO:0002102 | podosome(GO:0002102) |
0.3 | 1.3 | GO:0008537 | proteasome activator complex(GO:0008537) |
0.3 | 3.0 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
0.3 | 6.5 | GO:0031362 | anchored component of external side of plasma membrane(GO:0031362) |
0.3 | 1.1 | GO:1990696 | USH2 complex(GO:1990696) |
0.3 | 7.3 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.3 | 15.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.2 | 0.5 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.2 | 2.2 | GO:0061574 | ASAP complex(GO:0061574) |
0.2 | 3.4 | GO:0001891 | phagocytic cup(GO:0001891) |
0.2 | 5.7 | GO:0043196 | varicosity(GO:0043196) |
0.2 | 6.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 10.7 | GO:0008180 | COP9 signalosome(GO:0008180) |
0.2 | 1.6 | GO:0097208 | alveolar lamellar body(GO:0097208) |
0.2 | 2.9 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.2 | 5.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.2 | 1.6 | GO:0000801 | central element(GO:0000801) |
0.2 | 3.6 | GO:0031527 | filopodium membrane(GO:0031527) |
0.2 | 2.9 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.1 | 6.2 | GO:0030139 | endocytic vesicle(GO:0030139) |
0.1 | 5.0 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.1 | 0.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 8.9 | GO:0005903 | brush border(GO:0005903) |
0.1 | 1.9 | GO:0031011 | Ino80 complex(GO:0031011) |
0.1 | 3.2 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.1 | 1.0 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 11.0 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 1.5 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 1.6 | GO:0030127 | COPII vesicle coat(GO:0030127) |
0.1 | 4.7 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.1 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.1 | 3.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.1 | 11.9 | GO:0000922 | spindle pole(GO:0000922) |
0.1 | 5.2 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 4.9 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.1 | 1.8 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.1 | 5.7 | GO:0031672 | A band(GO:0031672) |
0.1 | 4.6 | GO:0097517 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 3.4 | GO:0097440 | apical dendrite(GO:0097440) |
0.1 | 3.6 | GO:0005720 | nuclear heterochromatin(GO:0005720) |
0.1 | 3.1 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 8.7 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 1.9 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 1.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.1 | 0.7 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 0.7 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 1.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.1 | 3.5 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 5.0 | GO:0031463 | Cul3-RING ubiquitin ligase complex(GO:0031463) |
0.1 | 0.2 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 11.6 | GO:0001726 | ruffle(GO:0001726) |
0.1 | 4.3 | GO:0005643 | nuclear pore(GO:0005643) |
0.1 | 4.3 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.1 | 0.9 | GO:0036038 | MKS complex(GO:0036038) |
0.1 | 1.8 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.1 | 5.2 | GO:0072562 | blood microparticle(GO:0072562) |
0.0 | 17.1 | GO:0009897 | external side of plasma membrane(GO:0009897) |
0.0 | 5.7 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.3 | GO:0034362 | low-density lipoprotein particle(GO:0034362) |
0.0 | 1.5 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.0 | 0.4 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.0 | 0.6 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.0 | 1.4 | GO:0005790 | smooth endoplasmic reticulum(GO:0005790) |
0.0 | 5.3 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 4.3 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 1.2 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 0.2 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.0 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.0 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.0 | 2.0 | GO:0031985 | Golgi cisterna(GO:0031985) |
0.0 | 0.2 | GO:0071598 | neuronal ribonucleoprotein granule(GO:0071598) |
0.0 | 2.3 | GO:0005814 | centriole(GO:0005814) |
0.0 | 2.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.0 | 0.4 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.0 | 0.5 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.0 | 4.3 | GO:0001650 | fibrillar center(GO:0001650) |
0.0 | 1.3 | GO:0032281 | AMPA glutamate receptor complex(GO:0032281) |
0.0 | 2.6 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.5 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.0 | 5.1 | GO:0098852 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
0.0 | 4.7 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.0 | 4.6 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.0 | 0.5 | GO:0014704 | intercalated disc(GO:0014704) |
0.0 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 3.3 | GO:0016324 | apical plasma membrane(GO:0016324) |
0.0 | 1.2 | GO:0005923 | bicellular tight junction(GO:0005923) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.7 | 17.0 | GO:0035717 | chemokine (C-C motif) ligand 7 binding(GO:0035717) |
3.8 | 15.2 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
2.9 | 22.9 | GO:0050786 | RAGE receptor binding(GO:0050786) |
2.8 | 14.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
2.1 | 23.0 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
2.0 | 14.2 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
1.9 | 5.8 | GO:0034437 | very-low-density lipoprotein particle binding(GO:0034189) glycoprotein transporter activity(GO:0034437) |
1.9 | 5.7 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
1.9 | 11.4 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
1.6 | 7.9 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
1.4 | 11.5 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.2 | 6.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
1.2 | 72.9 | GO:0004601 | peroxidase activity(GO:0004601) |
1.1 | 11.5 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
1.1 | 4.6 | GO:0086077 | gap junction channel activity involved in AV node cell-bundle of His cell electrical coupling(GO:0086077) |
1.1 | 11.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
1.0 | 3.0 | GO:0052593 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
1.0 | 12.8 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.0 | 3.8 | GO:0030369 | ICAM-3 receptor activity(GO:0030369) |
0.9 | 4.6 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.9 | 4.4 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.8 | 3.1 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
0.8 | 6.1 | GO:0015181 | arginine transmembrane transporter activity(GO:0015181) |
0.7 | 6.0 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.7 | 2.9 | GO:0000822 | inositol hexakisphosphate binding(GO:0000822) |
0.7 | 0.7 | GO:0031798 | type 1 metabotropic glutamate receptor binding(GO:0031798) |
0.7 | 2.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.6 | 2.6 | GO:0019767 | IgE receptor activity(GO:0019767) |
0.6 | 5.1 | GO:0030911 | TPR domain binding(GO:0030911) |
0.6 | 7.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 3.0 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
0.6 | 4.8 | GO:0004064 | arylesterase activity(GO:0004064) |
0.6 | 9.9 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.6 | 4.5 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.6 | 2.2 | GO:1990460 | leptin receptor binding(GO:1990460) |
0.5 | 4.7 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.5 | 4.4 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.5 | 60.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.4 | 4.0 | GO:0034711 | inhibin binding(GO:0034711) |
0.4 | 21.7 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) |
0.4 | 3.3 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.4 | 2.5 | GO:0004359 | glutaminase activity(GO:0004359) |
0.4 | 3.2 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.4 | 13.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.4 | 6.1 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
0.4 | 6.0 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.4 | 1.5 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.4 | 8.9 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.3 | 1.0 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.3 | 11.1 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.3 | 11.1 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.3 | 6.6 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.3 | 4.3 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.3 | 3.6 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.3 | 1.2 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
0.3 | 1.5 | GO:0043515 | kinetochore binding(GO:0043515) |
0.3 | 6.0 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.3 | 5.0 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.3 | 15.1 | GO:0035591 | signaling adaptor activity(GO:0035591) |
0.3 | 7.6 | GO:0001968 | fibronectin binding(GO:0001968) |
0.3 | 1.0 | GO:0001847 | opsonin receptor activity(GO:0001847) |
0.2 | 2.9 | GO:0050700 | CARD domain binding(GO:0050700) |
0.2 | 14.6 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.2 | 1.8 | GO:0061578 | Lys63-specific deubiquitinase activity(GO:0061578) |
0.2 | 2.9 | GO:0004579 | oligosaccharyl transferase activity(GO:0004576) dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.2 | 5.2 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.2 | 1.9 | GO:0005004 | GPI-linked ephrin receptor activity(GO:0005004) |
0.2 | 6.9 | GO:0043274 | phospholipase binding(GO:0043274) |
0.2 | 1.3 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 7.0 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.2 | 4.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.2 | 8.4 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.2 | 2.4 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.2 | 2.5 | GO:0031957 | very long-chain fatty acid-CoA ligase activity(GO:0031957) |
0.2 | 1.5 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.2 | 1.7 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.2 | 0.7 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.2 | 33.7 | GO:0017124 | SH3 domain binding(GO:0017124) |
0.2 | 7.0 | GO:0030544 | Hsp70 protein binding(GO:0030544) |
0.2 | 2.3 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.2 | 0.5 | GO:0004911 | interleukin-2 receptor activity(GO:0004911) |
0.2 | 3.1 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.2 | 1.3 | GO:0016531 | copper chaperone activity(GO:0016531) cuprous ion binding(GO:1903136) |
0.2 | 3.1 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.2 | 0.5 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.1 | 0.9 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.1 | 1.3 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
0.1 | 1.5 | GO:0070181 | small ribosomal subunit rRNA binding(GO:0070181) |
0.1 | 4.0 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 1.3 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.1 | 4.7 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
0.1 | 1.5 | GO:0008179 | adenylate cyclase binding(GO:0008179) |
0.1 | 1.1 | GO:0050291 | sphingosine N-acyltransferase activity(GO:0050291) |
0.1 | 4.2 | GO:0000062 | fatty-acyl-CoA binding(GO:0000062) |
0.1 | 5.7 | GO:0005546 | phosphatidylinositol-4,5-bisphosphate binding(GO:0005546) |
0.1 | 4.1 | GO:0003785 | actin monomer binding(GO:0003785) |
0.1 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.1 | 3.2 | GO:0005031 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.9 | GO:1990948 | ligase inhibitor activity(GO:0055104) ubiquitin ligase inhibitor activity(GO:1990948) |
0.1 | 1.7 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 0.8 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.1 | 3.9 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 1.8 | GO:0035173 | histone kinase activity(GO:0035173) |
0.1 | 3.4 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 4.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 1.4 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 1.8 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.1 | 2.6 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.1 | 0.2 | GO:0004487 | methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
0.1 | 0.7 | GO:0051400 | BH domain binding(GO:0051400) |
0.1 | 2.9 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.1 | 1.3 | GO:0032041 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.1 | 8.8 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
0.1 | 1.9 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 1.0 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.1 | 4.3 | GO:0009055 | electron carrier activity(GO:0009055) |
0.1 | 5.1 | GO:0003724 | RNA helicase activity(GO:0003724) ATP-dependent RNA helicase activity(GO:0004004) |
0.1 | 2.9 | GO:0004620 | phospholipase activity(GO:0004620) |
0.1 | 4.0 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.2 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.1 | 1.1 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.0 | 1.8 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.3 | GO:0016428 | tRNA (cytosine-5-)-methyltransferase activity(GO:0016428) |
0.0 | 0.2 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.0 | 0.2 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.0 | 0.2 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.0 | 0.7 | GO:0035198 | miRNA binding(GO:0035198) |
0.0 | 0.2 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.0 | 9.1 | GO:0044822 | mRNA binding(GO:0003729) poly(A) RNA binding(GO:0044822) |
0.0 | 1.6 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
0.0 | 15.2 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 1.6 | GO:0004864 | protein phosphatase inhibitor activity(GO:0004864) |
0.0 | 4.2 | GO:0019903 | protein phosphatase binding(GO:0019903) |
0.0 | 0.6 | GO:0017075 | syntaxin-1 binding(GO:0017075) |
0.0 | 1.2 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.0 | 0.3 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
0.0 | 1.2 | GO:0015175 | neutral amino acid transmembrane transporter activity(GO:0015175) |
0.0 | 0.4 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.0 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.2 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0034431 | endopolyphosphatase activity(GO:0000298) diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) bis(5'-adenosyl)-hexaphosphatase activity(GO:0034431) bis(5'-adenosyl)-pentaphosphatase activity(GO:0034432) |
0.0 | 0.7 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.3 | GO:0046527 | glucosyltransferase activity(GO:0046527) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 2.2 | GO:0046332 | SMAD binding(GO:0046332) |
0.0 | 0.5 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 1.4 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
0.0 | 0.8 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
0.0 | 1.1 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.0 | 0.8 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.2 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.0 | 0.2 | GO:0071889 | 14-3-3 protein binding(GO:0071889) |
0.0 | 0.6 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.2 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.7 | 88.0 | PID IL23 PATHWAY | IL23-mediated signaling events |
1.0 | 13.9 | PID S1P S1P4 PATHWAY | S1P4 pathway |
1.0 | 11.4 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.8 | 14.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.8 | 13.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.7 | 27.8 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.5 | 8.1 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.4 | 7.5 | PID THROMBIN PAR4 PATHWAY | PAR4-mediated thrombin signaling events |
0.4 | 5.6 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.4 | 16.6 | PID REELIN PATHWAY | Reelin signaling pathway |
0.4 | 19.3 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.4 | 8.0 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.4 | 13.6 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.4 | 8.1 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.4 | 12.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.4 | 10.7 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.4 | 22.1 | PID PLK1 PATHWAY | PLK1 signaling events |
0.3 | 12.9 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
0.3 | 3.8 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.3 | 8.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.3 | 7.5 | PID CD40 PATHWAY | CD40/CD40L signaling |
0.3 | 10.3 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.3 | 15.1 | PID BCR 5PATHWAY | BCR signaling pathway |
0.3 | 10.9 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
0.3 | 2.4 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 9.0 | PID AURORA B PATHWAY | Aurora B signaling |
0.2 | 3.6 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.2 | 10.6 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
0.2 | 6.9 | PID ERBB1 INTERNALIZATION PATHWAY | Internalization of ErbB1 |
0.2 | 6.8 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.2 | 4.4 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
0.1 | 25.6 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.1 | 2.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 4.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.1 | 1.2 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.1 | 3.0 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.1 | 2.8 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
0.1 | 1.9 | PID RHOA PATHWAY | RhoA signaling pathway |
0.1 | 0.8 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 5.7 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.1 | 1.4 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.1 | 1.9 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.1 | 4.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.1 | 13.8 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.1 | 1.8 | PID CDC42 PATHWAY | CDC42 signaling events |
0.1 | 3.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 2.2 | ST INTEGRIN SIGNALING PATHWAY | Integrin Signaling Pathway |
0.1 | 1.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
0.0 | 0.6 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.0 | 0.8 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 1.3 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.8 | PID RAS PATHWAY | Regulation of Ras family activation |
0.0 | 1.8 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 1.8 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.0 | 1.5 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.0 | 0.6 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 1.4 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.6 | PID P53 REGULATION PATHWAY | p53 pathway |
0.0 | 0.2 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.5 | 3.0 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
1.3 | 7.8 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.1 | 14.2 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.0 | 17.2 | REACTOME CD28 DEPENDENT VAV1 PATHWAY | Genes involved in CD28 dependent Vav1 pathway |
0.9 | 10.9 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
0.9 | 11.5 | REACTOME THE NLRP3 INFLAMMASOME | Genes involved in The NLRP3 inflammasome |
0.8 | 11.4 | REACTOME COMMON PATHWAY | Genes involved in Common Pathway |
0.7 | 15.3 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.7 | 7.5 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.6 | 12.8 | REACTOME INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS | Genes involved in Inhibition of the proteolytic activity of APC/C required for the onset of anaphase by mitotic spindle checkpoint components |
0.6 | 24.5 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.5 | 7.4 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.5 | 11.4 | REACTOME BASIGIN INTERACTIONS | Genes involved in Basigin interactions |
0.5 | 0.5 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.4 | 4.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.4 | 13.5 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
0.4 | 18.7 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.4 | 18.6 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.4 | 4.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.3 | 5.0 | REACTOME ADENYLATE CYCLASE ACTIVATING PATHWAY | Genes involved in Adenylate cyclase activating pathway |
0.3 | 5.7 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.3 | 7.0 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.3 | 4.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.3 | 9.0 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.3 | 11.5 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.3 | 3.1 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.3 | 3.6 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.3 | 2.0 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.2 | 2.7 | REACTOME PROSTANOID LIGAND RECEPTORS | Genes involved in Prostanoid ligand receptors |
0.2 | 1.5 | REACTOME INFLAMMASOMES | Genes involved in Inflammasomes |
0.2 | 18.5 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.2 | 16.4 | REACTOME NRAGE SIGNALS DEATH THROUGH JNK | Genes involved in NRAGE signals death through JNK |
0.2 | 9.6 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.2 | 4.6 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.2 | 2.9 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.2 | 6.3 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.2 | 8.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 4.2 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 4.6 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.1 | 5.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.4 | REACTOME P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS | Genes involved in p130Cas linkage to MAPK signaling for integrins |
0.1 | 1.8 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.1 | 2.5 | REACTOME GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Glutamate Neurotransmitter Release Cycle |
0.1 | 1.8 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.1 | 2.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.1 | 10.8 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.1 | 1.9 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 6.4 | REACTOME APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS | Genes involved in Apoptotic cleavage of cellular proteins |
0.1 | 2.1 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 15.8 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.1 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 4.6 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 1.8 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.1 | 1.3 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
0.1 | 0.9 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 7.5 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
0.1 | 1.5 | REACTOME SIGNALING BY ROBO RECEPTOR | Genes involved in Signaling by Robo receptor |
0.1 | 3.4 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 5.9 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.0 | 0.5 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 2.9 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.0 | 1.1 | REACTOME TRANSPORT OF RIBONUCLEOPROTEINS INTO THE HOST NUCLEUS | Genes involved in Transport of Ribonucleoproteins into the Host Nucleus |
0.0 | 0.5 | REACTOME SIGNALING BY PDGF | Genes involved in Signaling by PDGF |
0.0 | 1.1 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.0 | 0.8 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
0.0 | 0.5 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.0 | 1.3 | REACTOME NOTCH1 INTRACELLULAR DOMAIN REGULATES TRANSCRIPTION | Genes involved in NOTCH1 Intracellular Domain Regulates Transcription |
0.0 | 1.1 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.5 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.0 | 0.6 | REACTOME ACTIVATION OF CHAPERONE GENES BY XBP1S | Genes involved in Activation of Chaperone Genes by XBP1(S) |
0.0 | 0.4 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.1 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |